Skip to main content
Erschienen in: Supportive Care in Cancer 12/2012

01.12.2012 | Original Article

A survey of the sedation practice of Portuguese palliative care teams

verfasst von: Ferraz Gonçalves, Aida Cordero, Ana Almeida, Arlindo Cruz, Céu Rocha, Madalena Feio, Paula Silva, Salomé Barbas, Sandra Neves

Erschienen in: Supportive Care in Cancer | Ausgabe 12/2012

Einloggen, um Zugang zu erhalten

Abstract

Aim

The purpose of this study is to study the practice of sedation by Portuguese palliative care teams.

Methods

The teams included on the website of the Portuguese Association for Palliative Care were invited to participate. Data from all the patients sedated between April and June 2010 were recorded. Sedation was defined as the intentional administration of sedative drugs for symptom control, except insomnia, independently of the consciousness level reached.

Results

Of the 19 teams invited only 4 actually participated. During the study period, 181 patients were treated: 171 (94 %) were cancer patients and 10 non-cancer patients. Twenty-seven (16 %) patients were sedated: 13 intermittently, 11 continuously, and 3 intermittently at first then continuously. The rate of sedation varied substantially among the teams. Delirium was the most frequent reason for sedation. Midazolam was the drug used in most cases. In 21 cases of sedation, the decision was made unilaterally by the professionals; in 16 (76 %) of those, the situation was deemed to be emergent. From the patients on continuous sedation, 9 (64 %) patients maintained oxygen, 13 (93 %) hydration, and 6 (43 %) nutrition. Two patients who had undergone intermittent sedation were discharged home and one was transferred to another institution; the reason for sedation in the three cases was delirium.

Conclusion

There is a substantial variation in the sedation rate among the teams. One of the most important aspects was the decision-making process which should be object of reflection and discussion in the teams.
Literatur
1.
Zurück zum Zitat Cherny NI, Portenoy RK (1994) Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 10:31–38PubMed Cherny NI, Portenoy RK (1994) Sedation in the management of refractory symptoms: guidelines for evaluation and treatment. J Palliat Care 10:31–38PubMed
2.
Zurück zum Zitat Cherny NI (1998) Commentary: sedation in response to refractory existential distress: walking the fine line. J Pain Symptom Manage 16:404–407PubMedCrossRef Cherny NI (1998) Commentary: sedation in response to refractory existential distress: walking the fine line. J Pain Symptom Manage 16:404–407PubMedCrossRef
3.
Zurück zum Zitat Ventafridda V, Ripamonti C, de Conno F, Tamburini M, Cassileth BR (1990) Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7–11PubMed Ventafridda V, Ripamonti C, de Conno F, Tamburini M, Cassileth BR (1990) Symptom prevalence and control during cancer patients' last days of life. J Palliat Care 6:7–11PubMed
4.
Zurück zum Zitat Claessens P, Menten J, Schotsmans P, Broeckaert B (2008) Palliative sedation: a review of the research literature. J Pain Symptom Manage 36:310–333PubMedCrossRef Claessens P, Menten J, Schotsmans P, Broeckaert B (2008) Palliative sedation: a review of the research literature. J Pain Symptom Manage 36:310–333PubMedCrossRef
5.
Zurück zum Zitat Ferraz Gonçalves J, Alvarenga M, Silva A (2003) The last forty-eight hours of life in a Portuguese palliative care unit: does it differ from elsewhere? J Palliat Med 6:895–900PubMedCrossRef Ferraz Gonçalves J, Alvarenga M, Silva A (2003) The last forty-eight hours of life in a Portuguese palliative care unit: does it differ from elsewhere? J Palliat Med 6:895–900PubMedCrossRef
6.
Zurück zum Zitat Chater S, Viola R, Paterson J, Jarvis V (1998) Sedation for intractable distress in the dying—a survey of experts. Palliat Med 12:255–269PubMedCrossRef Chater S, Viola R, Paterson J, Jarvis V (1998) Sedation for intractable distress in the dying—a survey of experts. Palliat Med 12:255–269PubMedCrossRef
7.
Zurück zum Zitat Morita T, Tsuneto S, Shima Y (2002) Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 24:447–453PubMedCrossRef Morita T, Tsuneto S, Shima Y (2002) Definition of sedation for symptom relief: a systematic literature review and a proposal of operational criteria. J Pain Symptom Manage 24:447–453PubMedCrossRef
8.
Zurück zum Zitat Gonçalves F, Bento MJ, Alvarenga M, Costa I, Costa L (2008) Validation of a consciousness level scale for palliative care. Palliat Med 22:724–729PubMedCrossRef Gonçalves F, Bento MJ, Alvarenga M, Costa I, Costa L (2008) Validation of a consciousness level scale for palliative care. Palliat Med 22:724–729PubMedCrossRef
10.
Zurück zum Zitat Elsayem A, Curry E III, Boohene J, Munsell MF, Calderon B, Hung F, Bruera E (2009) Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer 17:53–59PubMedCrossRef Elsayem A, Curry E III, Boohene J, Munsell MF, Calderon B, Hung F, Bruera E (2009) Use of palliative sedation for intractable symptoms in the palliative care unit of a comprehensive cancer center. Support Care Cancer 17:53–59PubMedCrossRef
11.
Zurück zum Zitat Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY (2001) Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 21:467–472PubMedCrossRef Chiu TY, Hu WY, Lue BH, Cheng SY, Chen CY (2001) Sedation for refractory symptoms of terminal cancer patients in Taiwan. J Pain Symptom Manage 21:467–472PubMedCrossRef
12.
Zurück zum Zitat Sykes N, Thorns A (2003) The use of opioids and sedatives at the end of life. Lancet Oncol 4:312–318PubMedCrossRef Sykes N, Thorns A (2003) The use of opioids and sedatives at the end of life. Lancet Oncol 4:312–318PubMedCrossRef
13.
Zurück zum Zitat Berger JT (2010) Rethinking guidelines for the use of palliative sedation. Hasting Center Report 40:32–38CrossRef Berger JT (2010) Rethinking guidelines for the use of palliative sedation. Hasting Center Report 40:32–38CrossRef
14.
Zurück zum Zitat Fainsinger RL, Waller A, Bercovici M et al (2000) A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14:257–265PubMedCrossRef Fainsinger RL, Waller A, Bercovici M et al (2000) A multicentre international study of sedation for uncontrolled symptoms in terminally ill patients. Palliat Med 14:257–265PubMedCrossRef
15.
Zurück zum Zitat Sales JP, Boré YC, Gil AE et al (1999) Estudio multicéntrico catalano-balear sobre la sedación terminal en Cuidados Paliativos. Pal Med 6:153–158 Sales JP, Boré YC, Gil AE et al (1999) Estudio multicéntrico catalano-balear sobre la sedación terminal en Cuidados Paliativos. Pal Med 6:153–158
16.
Zurück zum Zitat Olsen ML, Swetz KM, Mueller PS (2010) Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments. Mayo Clin Proc 85:949–954PubMedCrossRef Olsen ML, Swetz KM, Mueller PS (2010) Ethical decision making with end-of-life care: palliative sedation and withholding or withdrawing life-sustaining treatments. Mayo Clin Proc 85:949–954PubMedCrossRef
17.
Zurück zum Zitat Cherny NI, Radbruch L (2009) Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23:581–593PubMedCrossRef Cherny NI, Radbruch L (2009) Board of the European Association for Palliative Care. European Association for Palliative Care (EAPC) recommended framework for the use of sedation in palliative care. Palliat Med 23:581–593PubMedCrossRef
18.
Zurück zum Zitat Reuz RPB, Hasselaar GJ, Vissers KCP, van der Wilt GJ, Groenewoud JMM, Crul BJP (2008) Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study. Palliat Med 22:641–646CrossRef Reuz RPB, Hasselaar GJ, Vissers KCP, van der Wilt GJ, Groenewoud JMM, Crul BJP (2008) Inappropriateness of using opioids for end-stage palliative sedation: a Dutch study. Palliat Med 22:641–646CrossRef
19.
Zurück zum Zitat Hasselaar JGJ, Reuzel RPB (2007) PhD; Verhagen SCAHHVM, de Graeff A, MD, Vissers KCP, Crul BJP. Improving prescription in palliative sedation compliance with Dutch guidelines. Arch Intern Med 167:1166–1171PubMedCrossRef Hasselaar JGJ, Reuzel RPB (2007) PhD; Verhagen SCAHHVM, de Graeff A, MD, Vissers KCP, Crul BJP. Improving prescription in palliative sedation compliance with Dutch guidelines. Arch Intern Med 167:1166–1171PubMedCrossRef
20.
Zurück zum Zitat Billings JA, Block S (1996) Slow euthanasia. J Palliat Care 12:21–30PubMed Billings JA, Block S (1996) Slow euthanasia. J Palliat Care 12:21–30PubMed
21.
Zurück zum Zitat Craig GM (1996) On withholding artificial hydration and nutrition from terminally ill sedated patients. The debate continues. J Med Ethics 22:147–153 Craig GM (1996) On withholding artificial hydration and nutrition from terminally ill sedated patients. The debate continues. J Med Ethics 22:147–153
22.
Zurück zum Zitat Sykes N, Thorns A (2003) Sedative use in the last weeks of life and the implications for end-of-life decision making. Arch Intern Med 163:341–344PubMedCrossRef Sykes N, Thorns A (2003) Sedative use in the last weeks of life and the implications for end-of-life decision making. Arch Intern Med 163:341–344PubMedCrossRef
23.
Zurück zum Zitat Maltoni M, Pittureri C, Scarpi E, Piccini L, Martini F, Turci P, Montanari L, Nanni O, Amadori D (2009) Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol 20:1163–1169PubMedCrossRef Maltoni M, Pittureri C, Scarpi E, Piccini L, Martini F, Turci P, Montanari L, Nanni O, Amadori D (2009) Palliative sedation therapy does not hasten death: results from a prospective multicenter study. Ann Oncol 20:1163–1169PubMedCrossRef
Metadaten
Titel
A survey of the sedation practice of Portuguese palliative care teams
verfasst von
Ferraz Gonçalves
Aida Cordero
Ana Almeida
Arlindo Cruz
Céu Rocha
Madalena Feio
Paula Silva
Salomé Barbas
Sandra Neves
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 12/2012
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-012-1442-7

Weitere Artikel der Ausgabe 12/2012

Supportive Care in Cancer 12/2012 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.